UCL-TB

UCL-TB

@ucltb.bsky.social

UCL-TB is a broad and cross-disciplinary tuberculosis research network that spans University College London and our partners throughout the world. We're also on X (@UCLTB). Website: https://www.ucl.ac.uk/tb/ YouTube: https://www.youtube.com/channel/UCUc

538 followers52 following17 posts

UCL-TB reposted

TB Centre LSHTM
@tb-lshtm.bsky.social

Did you miss @tb-lshtm.bsky.social & @ucltb.bsky.social Symposium? Or would you like to watch again? Good news: the full recording is now available! tinyurl.com/bdh8fymx @sedonasweeney.bsky.social @kchorton.bsky.social @reinhouben.bsky.social

tinyurl.comWorld TB Day Symposium 2025 | LSHTMPlease note more tickets are now available via the link below. On 24 March each year, the world commemorates the day in 1882 when Dr Robert Koch announced his discovery of Mycobacterium tuberculosis
This post is unavailable.
UCL-TB
@ucltb.bsky.social

Out today: The need to scale up community-wide screening for TB irrespective of symptoms, if we are serious about ending TB. ijidonline.com/article/S120... @mrcctu.bsky.social

ijidonline.comScaling-up symptom-agnostic, community-wide screening towards global tuberculosis elimination: opportunities, challenges and lessons from historyGlobally in 2023, 8.2 million people with a new episode of tuberculosis (TB) were diagnosed and notified.[1] This is the highest number of TB notifications for a single year since the World Health Org...
UCL-TB
@ucltb.bsky.social

1 week today until our World TB Day Symposium! Join us in-person (more tickets available) or online.

Katherine Horton@kchorton.bsky.social

Register now to join us for this year's #WTBD symposium! With sessions on post-TB lung disease, the UK's place in national and international policy, and asymptomatic TB, plus a debate on Pan-TB regimens and turbo talks from early career researchers @tb-lshtm.bsky.social & @ucltb.bsky.social!

UCL-TB reposted

btnin24.bsky.social
@btnin24.bsky.social

Excellent work by @msf.ca @msfsci.bsky.social, @who.int, Uzbekistan and Belarusian colleagues on real world evidence for #BPaLM and #BPaLC 6 months treatment for rifampicin-resistant #TB @lshtmamrcentre.bsky.social @ucltb.bsky.social

academic.oup.comThe Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbek...Treatment for multidrug-resistant/rifampicin-resistant tuberculosis (TB) and pre–extensively drug-resistant TB using 24-week all-oral bedaquiline, pretoman

UCL-TB reposted

Gabriele Pollara
@gpollara.bsky.social

Bedaquiline has been a great development in the treatment of drug-resistant TB. But it's future is uncertain due to rising resistance levels. Great review here.... #IDSky #Microsky #Infectiousdiseases #TB #Tuberculosis www.sciencedirect.com/science/arti...

sciencedirect.comBedaquiline: what might the future hold?Tuberculosis drug development has stagnated for decades, so the recent availability of bedaquiline is welcome. Bedaquiline-containing regimens, now th…

UCL-TB reposted

Emily Wong
@emilybethwong.bsky.social

Thanks for this beautiful 🧵! Wonderful to work with @gpollara.bsky.social @helgardclaassen.bsky.social and @maphemthembu.bsky.social on this. Appreciate the support from @niaidnews.bsky.social @ahri-news.bsky.social and @ucltb.bsky.social. 3rd and final PhD paper for Maphe! 🎉 💫

Gabriele Pollara@gpollara.bsky.social

Really pleased to share collaborative project led by @emilybethwong.bsky.social & 1st author @maphemthembu.bsky.social A careful dissection of dysfunctional immune responses in ART-naive HIV infection. TL:DR bronchoalveolar ≠ blood responses #HIVSky #IDSky #ImmunoSky www.cell.com/iscience/ful...

cell.comDysfunctional bronchoalveolar effector memory CD8+ T cells in tuberculosis-exposed people living with antiretroviral-naïve HIV infectionImmunology; Virology

UCL-TB reposted

UCL Innovative Clinical Trials Unit
@innovative-ctu.bsky.social

Today at the #UnionConf2024, Trinh Duong discussed safety of and adherence to levofloxacin to prevent multidrug-resistant #tuberculosis in the TB-CHAMP & VQUIN trials. Get the full story behind these #TB trials on our podcast. Listen now👇 https://buff.ly/4euqqTG #MedSky #IDSky @ucltb.bsky.social

buff.lyTB-CHAMP, VQUIN, and the first effective treatment to prevent multidrug-resistant tuberculosisIn September 2024, the World Health Organization (WHO) released new guidance on preventative treatment for tuberculosis (TB). Thanks to new evidence from two randomised controlled clinical trials, the

You are up to date.